In the relentless pursuit of effective treatments and early diagnostic tools for Alzheimer's disease, advanced chemical compounds play a pivotal role. Among these, 6-OH-BTA-0, identified by its CAS number 178804-18-7, stands out as a critical precursor. NINGBO INNO PHARMCHEM CO.,LTD. recognizes the significance of this fine chemical intermediate in the development of Positron Emission Tomography (PET) imaging agents, particularly the well-known Pittsburgh Compound B, or 11C-PiB. This compound's ability to act as a precursor for such diagnostic tools underscores its importance in the field of neuroscience and medical imaging.

The development of accurate and sensitive diagnostic methods is paramount for managing Alzheimer's disease. PET imaging offers a non-invasive way to visualize and quantify the beta-amyloid plaques in the brain, which are hallmarks of the disease. The synthesis of the radiotracer 11C-PiB relies heavily on high-quality precursors like 6-OH-BTA-0. The reliable supply of this chemical intermediate is therefore essential for researchers and clinicians working on early detection and monitoring of Alzheimer's progression. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing researchers with the necessary materials to push the boundaries of medical diagnostics.

Beyond its application in PET imaging, 6-OH-BTA-0 also finds utility as an intermediate in the synthesis of various other important chemicals, including synthetic pesticides. This dual-purpose nature highlights the versatility of this compound within the chemical industry. For those looking to purchase 6-OH-BTA-0, understanding its applications and sourcing it from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. ensures the quality and consistency needed for critical research and development projects. The availability of 6-OH-BTA-0 at competitive prices is a key factor for many research institutions and pharmaceutical companies.